This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it with age.

ANSWER: This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it ...

This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it with age.

I thought you could help with a stubborn problem. I am a healthy and active 78-year-old woman who, I admit, likes to look ...

Patient endorsed history of chronic sinusitis with nasal polyps and underwent sinus surgery twice in the past. He denied allergies to NSAIDs or aspirin, and he was referred to ENT and was found to ...

I thought you could help with a stubborn problem. I am a healthy and active 78-year-old woman who, I admit, likes to look younger than my age. The problem is my skin, especially on my hands and arms; ...

Asthma and Antibiotic Use May Predict Nasal Polyp Recurrence After Endoscopic ... Burning Incense Can Pose Health Risks for Those With Allergies and Asthma Oct. 24, 2024 — A new medically ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

Learn more about whether Alvotech or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Learn more about whether Alvotech or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) for the treatment of chronic spontaneous ...